• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA NEARPORT 18GA X 1.25IN W/ MAXZERO; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA NEARPORT 18GA X 1.25IN W/ MAXZERO; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 393529
Medical Device Problem Code Defective Component (2292)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/10/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that bd nexiva nearport 18ga x 1.25in w/ maxzero needle retraction failed.It was reported by customer that iv went in perfectly but when we went to take out the needle it was stuck and would not detach from the iv.We had to take it out and even after it was still stuck.Verbatim #: "we had an instance where an iv went in perfectly but when we went to take out the needle it was stuck and would not detach from the iv.We had to take it out and even after it was still stuck.".
 
Additional Manufacturer Narrative
If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
Investigation results: our quality engineer inspected the 1 photo submitted for evaluation.The reported issue of needle retraction failure was confirmed upon inspection of the photo.However, bd cannot confirm the cause of the failure since no sample was returned for evaluation.We would be very interested in examining product that does not meet your expectations and our quality standards.Examination of the actual product involved may provide clarification as to the cause of the reported failure.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.Production records were reviewed, and this batch meets our manufacturing specification requirements.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA NEARPORT 18GA X 1.25IN W/ MAXZERO
Common Device Name
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key21286731
Report Number9610847-2025-00009
Device Sequence Number20810451
Product Code FOZ
UDI-Device Identifier00382903935291
UDI-Public(01)00382903935291(11)240726(17)270630(10)4191986
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K231239
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number393529
Device Lot Number4191986
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/13/2025
Supplement Date Received by Manufacturer02/11/2025
Initial Report FDA Received Date01/31/2025
Supplement Report FDA Received Date02/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/26/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-